Sponsor
University of California, San Francisco
Status
Not yet recruiting
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT06949800
This study is focused on treatment of anal high-grade squamous intraepithelial lesions (HSIL) in persons with HIV (PWH), with the ultimate goal of applying the approach toward prevention of anal cancer in this population
Intervention
EXE-346 Probiotic, Placebo, Usual Care High Resolution Anoscopy (HRA)
Condition
HSIL, High Grade Squamous Intraepithelial Lesion, HPV-Related Squamous Cell Carcinoma, Anal HSIL
Investigators
Joel Palefsky, MD, Salim Abraham Barquet-Munoz, MD,MSc, PhD, Ana Patricia Ortiz Martinez, MPH, MD